{"nct_id":"NCT04534205","title":"A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2021-01-07","start_date_type":"ACTUAL","primary_completion_date":"2029-04","primary_completion_date_type":"ESTIMATED","completion_date":"2029-04","completion_date_type":"ESTIMATED","phases":["PHASE2","PHASE3"],"tickers":["BNTX"]}